| Accession Number | 0001022079-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP for Diagnostic Services | Common Stock | โ | Jan 28, 2026 | Grant/Award | 48 | $183.51 | $8,808.58 | 15,381 | Direct | โ | View Details | |
SVP for Diagnostic Services | Common Stock | โ | Feb 10, 2026 | Exercise/Conversion | 5,662 | $121.81 | $689,659.91 | 21,043 | Direct | โ | View Details | |
SVP for Diagnostic Services | Common Stock | โ | Feb 10, 2026 | Sale | 5,662 | $204.00 | $1,155,048.00 | 15,381 | Direct | โ | View Details | |
SVP for Diagnostic Services | Non-Qualifed Stock Option (right to buy) | Derivative | Feb 10, 2026 | Exercise/Conversion | 5,662 | $121.81 | $689,659.91 | 0 | Direct | โ | View Details |